ZA200806318B - Drug combinations - Google Patents
Drug combinationsInfo
- Publication number
- ZA200806318B ZA200806318B ZA200806318A ZA200806318A ZA200806318B ZA 200806318 B ZA200806318 B ZA 200806318B ZA 200806318 A ZA200806318 A ZA 200806318A ZA 200806318 A ZA200806318 A ZA 200806318A ZA 200806318 B ZA200806318 B ZA 200806318B
- Authority
- ZA
- South Africa
- Prior art keywords
- drug combinations
- drug
- combinations
- Prior art date
Links
- 239000000890 drug combination Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0600709.0A GB0600709D0 (en) | 2006-01-13 | 2006-01-13 | Drug combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200806318B true ZA200806318B (en) | 2009-10-28 |
Family
ID=35998020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200806318A ZA200806318B (en) | 2006-01-13 | 2007-01-15 | Drug combinations |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090221656A1 (zh) |
| EP (1) | EP1983982A1 (zh) |
| JP (1) | JP2009523720A (zh) |
| KR (1) | KR20080092436A (zh) |
| CN (1) | CN101384257A (zh) |
| AU (1) | AU2007205298A1 (zh) |
| BR (1) | BRPI0706863A2 (zh) |
| CA (1) | CA2636941A1 (zh) |
| GB (1) | GB0600709D0 (zh) |
| MX (1) | MX2008009044A (zh) |
| RU (1) | RU2008133215A (zh) |
| WO (1) | WO2007081232A1 (zh) |
| ZA (1) | ZA200806318B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011506315A (ja) * | 2007-12-05 | 2011-03-03 | バイアル−ポルテラ アンド シーエー，エス．エー． | 新たな塩、及び結晶形 |
| WO2010065489A1 (en) * | 2008-12-02 | 2010-06-10 | Sciele Pharma, Inc. | Alpha2-adrenergic agonist and angiotensin ii receptor antagonist composition |
| WO2011133212A1 (en) * | 2010-04-20 | 2011-10-27 | New York University | Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders |
| CN102247345A (zh) * | 2011-05-30 | 2011-11-23 | 北京阜康仁生物制药科技有限公司 | 一种新型降血脂组合物 |
| KR102259938B1 (ko) * | 2012-11-14 | 2021-06-03 | 바이알 - 포르텔라 앤드 씨에이 에스에이 | 폐동맥 고혈압 및 폐 손상의 치료에 이용하기 위한 1,3-디히드로이미다졸-2-티온 유도체 |
| KR101771766B1 (ko) * | 2013-12-30 | 2017-08-28 | 알보젠코리아 주식회사 | 안지오텐신-Ⅱ 수용체 차단제 및 HMG-CoA 환원효소 저해제를 포함하는 약제학적 복합제제 |
| KR20150120008A (ko) * | 2014-04-16 | 2015-10-27 | 씨제이헬스케어 주식회사 | 비소프롤롤 및 로수바스타틴을 포함하는 경구용 약제학적 복합제제 |
| WO2016191294A1 (en) * | 2015-05-22 | 2016-12-01 | The Trustees Of Columbia University In The City Of New York | Sk and ik channel agonists for treatment of heart failure |
| KR101710441B1 (ko) | 2015-12-28 | 2017-02-28 | 신풍제약주식회사 | 안정성 및 용출성이 향상된 정제 |
| CN107569495A (zh) * | 2017-08-10 | 2018-01-12 | 新疆医科大学 | 依普利酮对慢性心力衰竭患者辅助性t细胞活化/增殖的抑制作用 |
| CN113599387B (zh) * | 2021-09-15 | 2023-03-28 | 山东中医药大学附属医院 | 一种复方制剂及其在制备治疗心绞痛药物中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217347A (en) * | 1977-12-27 | 1980-08-12 | E. R. Squibb & Sons, Inc. | Method of treating hypertension and medicaments therefor |
| JPS625964A (ja) * | 1985-07-01 | 1987-01-12 | Shionogi & Co Ltd | ５，６，７，８−テトラヒドロ−５，８−メタノイソキノリン誘導体および抗潰瘍剤 |
| JPS63286408A (ja) * | 1987-04-30 | 1988-11-24 | ワツカー−ケミー・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 極性化合物の重合法 |
| US5438150A (en) * | 1994-04-26 | 1995-08-01 | Syntex (U.S.A.) Inc. | Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives |
| US5538988A (en) * | 1994-04-26 | 1996-07-23 | Martinez; Gregory R. | Benzocycloalkylazolethione derivatives |
| RU2145321C1 (ru) * | 1994-04-26 | 2000-02-10 | Синтекс (Ю.Эс.Эй) Инк. | Производные бензоциклоалкилазолотиона |
| US7125904B2 (en) * | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
-
2006
- 2006-01-13 GB GBGB0600709.0A patent/GB0600709D0/en not_active Ceased
-
2007
- 2007-01-15 WO PCT/PT2007/000002 patent/WO2007081232A1/en active Application Filing
- 2007-01-15 CA CA002636941A patent/CA2636941A1/en not_active Abandoned
- 2007-01-15 JP JP2008550258A patent/JP2009523720A/ja active Pending
- 2007-01-15 MX MX2008009044A patent/MX2008009044A/es not_active Application Discontinuation
- 2007-01-15 CN CNA2007800053030A patent/CN101384257A/zh active Pending
- 2007-01-15 AU AU2007205298A patent/AU2007205298A1/en not_active Abandoned
- 2007-01-15 ZA ZA200806318A patent/ZA200806318B/xx unknown
- 2007-01-15 BR BRPI0706863-8A patent/BRPI0706863A2/pt not_active IP Right Cessation
- 2007-01-15 US US12/160,762 patent/US20090221656A1/en not_active Abandoned
- 2007-01-15 EP EP07709265A patent/EP1983982A1/en not_active Withdrawn
- 2007-01-15 RU RU2008133215/15A patent/RU2008133215A/ru not_active Application Discontinuation
- 2007-01-15 KR KR1020087019668A patent/KR20080092436A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008009044A (es) | 2008-11-14 |
| WO2007081232A1 (en) | 2007-07-19 |
| CA2636941A1 (en) | 2007-07-19 |
| CN101384257A (zh) | 2009-03-11 |
| BRPI0706863A2 (pt) | 2011-04-12 |
| GB0600709D0 (en) | 2006-02-22 |
| US20090221656A1 (en) | 2009-09-03 |
| RU2008133215A (ru) | 2010-02-20 |
| JP2009523720A (ja) | 2009-06-25 |
| EP1983982A1 (en) | 2008-10-29 |
| AU2007205298A1 (en) | 2007-07-19 |
| AU2007205298A8 (en) | 2008-08-28 |
| KR20080092436A (ko) | 2008-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1992348A4 (en) | PHARMACEUTICAL COMBINATION | |
| GB2436526B (en) | Syringe | |
| HK1125295A1 (zh) | 基於微片的藥物製劑 | |
| IL194762A0 (en) | Pharmaceutical compounds | |
| GB0608820D0 (en) | Pharmaceutical compounds | |
| ZA200806318B (en) | Drug combinations | |
| GB0603926D0 (en) | Syringes | |
| EP2015810A4 (en) | IMPROVED SYRINGE | |
| IL197883A0 (en) | Combination drug | |
| GB0625783D0 (en) | Medicament | |
| GB0608046D0 (en) | Syringe | |
| GB0615064D0 (en) | Medicament | |
| GB0613031D0 (en) | Medicaments | |
| GB0608184D0 (en) | Pharmaceutical compounds | |
| GB0608176D0 (en) | Pharmaceutical Compounds | |
| GB0608996D0 (en) | Drug counter | |
| GB0608264D0 (en) | Pharmaceutical compounds | |
| GB0615814D0 (en) | Medicament | |
| GB0717450D0 (en) | Medicament | |
| GB0625682D0 (en) | Pharmaceutical compounds | |
| GB0622892D0 (en) | Pharmaceutical compounds | |
| GB0608175D0 (en) | Pharmaceutical Compounds | |
| ZA200708369B (en) | Medicament | |
| GB0622332D0 (en) | Drug | |
| ZA200902756B (en) | Combination drug |